Cargando…
Atrial fibrillation in heart failure patients: An update on renin–angiotensin–aldosterone system pathway blockade as a therapeutic and prevention target
Heart failure (HF) and atrial fibrillation (AF) are two cardiovascular (CV) entities that affect millions of individuals worldwide and their prevalence is translated into a significant impact on health care systems. The common pathophysiological pathways that these two share have created an importan...
Autores principales: | Koniari, Ioanna, Artopoulou, Eleni, Mplani, Virginia, Mulita, Francesk, Alexopoulou, Evangelia, Chourdakis, Emmanouil, Abo-Elseoud, Mohammed, Tsigkas, Grigorios, Panagiotopoulos, Ioannis, Kounis, Nicholas, Velissaris, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129256/ https://www.ncbi.nlm.nih.gov/pubmed/35762070 http://dx.doi.org/10.5603/CJ.a2022.0061 |
Ejemplares similares
-
Digoxin Impact on Heart Failure Patients with Atrial Fibrillation
por: Gerakaris, Andreas, et al.
Publicado: (2022) -
Effect of atrial fibrillation on cognitive function in heart failure patients
por: Ktenopoulos, Nikolaos, et al.
Publicado: (2021) -
Biomarkers in the clinical management of patients with atrial fibrillation and heart failure
por: Koniari, Ioanna, et al.
Publicado: (2021) -
Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management
por: Koniari, Ioanna, et al.
Publicado: (2021) -
Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives
por: Chourdakis, Emmanouil, et al.
Publicado: (2021)